<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-vaccines-07-00053">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Giezeman</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Nauta</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>de Bruijn</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Palache</surname>
    <given-names>A.M.</given-names>
   </name>
  </person-group>
  <article-title>Trivalent inactivated subunit influenza vaccine Influvac (R): 25-Year experience of safety and immunogenicity</article-title>
  <source>Vaccine</source>
  <year>2009</year>
  <volume>27</volume>
  <fpage>2414</fpage>
  <lpage>2417</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.02.008</pub-id>
  <pub-id pub-id-type="pmid">19368782</pub-id>
 </element-citation>
</ref>
